Ovarian cancer statistics, 2018. CA Cancer J Clin 2018;68:284-96.Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin 2018;68:284-96.Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J Clin...
Ovarian cancer statistics Learn more about the latest ovarian cancer statistics, including survival, mortality and incidence data, from Cancer Research UK. UK Cancer - Cancer Research UK 被引量: 30发表: 2015年 Ovarian cancer incidence statistics Learn more about the latest ovarian cancer incidence ...
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors, cells of origin, molecular compositions, clinical features and treatments. Ovarian cancer is a global problem, is typically diagnosed at a late...
Many of the tests used to diagnose ovarian cancer do not reduce mortality from the disease or improve patients' quality of life, according to a new report supported by a partnership of the Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention. Annually, ...
Ovarian cancer statistics. [ cited 2023 Nov 15]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer#heading-Zero(open in a new window) (Open in a new window)Google Scholar National Institute for Health and Care ...
Epithelial ovarian cancer (EOC) is a deadly disease with limited diagnostic biomarkers and therapeutic targets. Here we conduct a comprehensive proteomic profiling of ovarian tissue and plasma samples from 813 patients with different histotypes and thera
National cancer society (USA) with reference to the National Cancer Institute and SEER database published the statistics of survival based on the research from 2004 till 2010. 5-year survival rate according to the stage: I 90% IA 94%
In 2023, the final PAOLA-1 trial (NCT02477644) survival data were published documenting the benefits of therapy consisting of olaparib plus bevacizumab for patients with advanced ovarian cancer (AOC) as a function of molecular status. In light of these new data, the present study was conducted ...
Figure 2. Clinical Summary: Screening for Ovarian Cancer View LargeDownload USPSTF indicates US Preventive Services Task Force. Podcast (19:37) USPSTF Recommendation: Screening for Ovarian Cancer 1x 0:00 / 0:00 1. US Cancer Statistics Working Group. United States Cancer Statistics (USCS): 1999...
Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96. Article PubMed PubMed Central Google Scholar Loomis D, Huang W, Chen G. The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China. Chin J ...